Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Therapeutic effects of biguanide vs. statin in polycystic ovary syndrome: a randomized clinical trial.

Navali N, Pourabolghasem S, Fouladi RF, Nikpour MA.

Pak J Biol Sci. 2011 Jun 1;14(11):658-63.

PMID:
22235508
2.

Statins for women with polycystic ovary syndrome not actively trying to conceive.

Raval AD, Hunter T, Stuckey B, Hart RJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD008565. doi: 10.1002/14651858.CD008565.pub2. Review.

PMID:
21975784
3.

Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.

Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ.

J Clin Endocrinol Metab. 2011 Nov;96(11):3493-501. doi: 10.1210/jc.2011-0501. Epub 2011 Aug 24.

4.

Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.

Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ.

J Clin Endocrinol Metab. 2009 Dec;94(12):4938-45. doi: 10.1210/jc.2009-1674. Epub 2009 Nov 4.

5.

Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.

Oner G, Muderris II.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):127-31. doi: 10.1016/j.ejogrb.2011.07.005. Epub 2011 Aug 9.

PMID:
21831508
6.
7.

Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.

Ghazeeri G, Abbas HA, Skaff B, Harajly S, Awwad J.

J Endocrinol Invest. 2015 Jun;38(6):643-51. doi: 10.1007/s40618-015-0237-3. Epub 2015 Feb 27.

PMID:
25722221
8.

Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.

Kriplani A, Agarwal N.

J Reprod Med. 2004 May;49(5):361-7.

PMID:
15214709
9.

Metformin improves menstrual patterns, endocrine and metabolic profile in obese hyperinsulinemic women with a polycystic ovary syndrome.

Krstevska B, Dimitrovski Ch, Pemovska G, Misevska S, Dimova Z, Simeonova S, Ahmeti I.

Prilozi. 2006 Jul;27(1):57-66.

PMID:
16862066
10.

Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study.

Kaya C, Pabuccu R, Cengiz SD, Dünder I.

Exp Clin Endocrinol Diabetes. 2010 Mar;118(3):161-6. doi: 10.1055/s-0029-1220770. Epub 2010 Feb 9.

PMID:
20146169
12.

Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.

Esfahanian F, Zamani MM, Heshmat R, Moini nia F.

J Obstet Gynaecol Res. 2013 Apr;39(4):806-13. doi: 10.1111/j.1447-0756.2012.02051.x. Epub 2012 Dec 21.

PMID:
23279603
13.

Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.

Kazerooni T, Dehghan-Kooshkghazi M.

Gynecol Endocrinol. 2003 Feb;17(1):51-6.

PMID:
12724019
14.

An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.

Sun J, Yuan Y, Cai R, Sun H, Zhou Y, Wang P, Huang R, Xia W, Wang S.

BMJ Open. 2015 Mar 27;5(3):e007280. doi: 10.1136/bmjopen-2014-007280. Review.

15.

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.

Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM.

Gynecol Endocrinol. 2007 Mar;23(3):146-52.

PMID:
17454168
16.
17.

The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.

Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.

Hum Reprod. 2005 Dec;20(12):3333-40. Epub 2005 Aug 25.

18.

Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.

Eur J Obstet Gynecol Reprod Biol. 2005 Dec 1;123(2):204-11.

PMID:
16316811
19.

Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.

Karakas SE, Banaszewska B, Spaczynski RZ, Pawelczyk L, Duleba A.

Gynecol Endocrinol. 2013 May;29(5):483-7. doi: 10.3109/09513590.2013.774360. Epub 2013 Mar 12.

PMID:
23480783
20.

Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.

Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ.

J Clin Endocrinol Metab. 2007 Feb;92(2):456-61. Epub 2006 Nov 14.

PMID:
17105841
Items per page

Supplemental Content

Write to the Help Desk